Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference48 articles.
1. Breast cancer treatment: a review;Waks;JAMA,2019
2. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
3. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005
4. Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer;Wei;Acta Pharm Sin B,2019
5. Immunological effects of conventional chemotherapy and targeted anticancer agents;Galluzzi;Cancer Cell,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance;Acta Pharmaceutica Sinica B;2024-01
2. Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis;Small Structures;2023-11-12
3. Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNFα/TNFR2-RUNX1-triggered G-CSF expression in endothelial cells;Biochemical Pharmacology;2023-11
4. The emerging tumor microbe microenvironment: from delineation to multidisciplinary approach-based interventions;Acta Pharmaceutica Sinica B;2023-11
5. Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells;Frontiers in Drug Delivery;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3